These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 29322472)

  • 1. The prevalence and risk factors of hepatitis B flares in chronic hepatitis B patients receiving glucocorticoid pulse therapy.
    Lin YC; Lee SW; Yeh HZ; Chang CS; Yang SS
    Int J Clin Pharm; 2018 Feb; 40(1):169-174. PubMed ID: 29322472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the timing of hepatitis B virus identification and anti-hepatitis B virus therapy initiation on the risk of adverse liver outcomes for patients receiving cancer therapy.
    Hwang JP; Suarez-Almazor ME; Cantor SB; Barbo A; Lin HY; Ahmed S; Chavez-MacGregor M; Donato-Santana C; Eng C; Ferrajoli A; Fisch MJ; McLaughlin P; Simon GR; Rondon G; Shpall EJ; Lok AS
    Cancer; 2017 Sep; 123(17):3367-3376. PubMed ID: 28518219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment response during Peg-interferon {alpha}-2b therapy.
    Flink HJ; Sprengers D; Hansen BE; van Zonneveld M; de Man RA; Schalm SW; Janssen HL;
    Gut; 2005 Nov; 54(11):1604-9. PubMed ID: 15923670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of dose and duration of corticosteroid on the risk of hepatitis flare in patients with chronic hepatitis B.
    Wong GL; Yuen BW; Chan HL; Tse YK; Yip TC; Lam KL; Lui GC; Wong VW
    Liver Int; 2019 Feb; 39(2):271-279. PubMed ID: 30179316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvements in hepatitis B virus screening before rituximab therapy: A community-based, safety-net hospital experience.
    Junus K; Aguilar M; Patel P; Irwin D; Yee S; Liu B; Bhuket T; Wong RJ
    Cancer; 2017 Feb; 123(4):650-656. PubMed ID: 27696389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum viral load at the virological relapse predicts subsequent clinical flares in chronic hepatitis B patients off entecavir therapy.
    Hsu YC; Mo LR; Chang CY; Wu MS; Yang TH; Kao JH; Chen CC; Tseng CH; Tai CM; Lin CW; Wu CY; Lin JT
    J Gastroenterol Hepatol; 2017 Aug; 32(8):1512-1519. PubMed ID: 28122151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between virological response and FIB-4 index in chronic hepatitis B patients with entecavir therapy.
    Li N; Xu JH; Yu M; Wang S; Si CW; Yu YY
    World J Gastroenterol; 2015 Nov; 21(43):12421-9. PubMed ID: 26604649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B surface antigen levels after hepatitis B e-antigen seroclearance: a longitudinal follow-up study.
    Fung J; Seto WK; Wong DK; Lai CL; Yuen MF
    Liver Int; 2015 Mar; 35(3):854-9. PubMed ID: 24840542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk of hepatitis B virus reactivation in systemic lupus erythematosus patients receiving immunosuppressants: a retrospective cohort study.
    Lin WT; Chen YM; Chen DY; Lan JL; Chang CS; Yeh HZ; Yang SS
    Lupus; 2018 Jan; 27(1):66-75. PubMed ID: 28534427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Undergoing Biologics Treatment.
    Chen MH; Chen MH; Liu CY; Tsai CY; Huang DF; Lin HY; Lee MH; Huang YH
    J Infect Dis; 2017 Feb; 215(4):566-573. PubMed ID: 28011918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive outcomes of on- and off-antiviral prophylaxis in hepatitis B patients undergoing cancer chemotherapy: A competing risks analysis.
    An J; Shim JH; Kim SO; Choi J; Kim SW; Lee D; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    J Med Virol; 2016 Sep; 88(9):1576-86. PubMed ID: 26945543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical efficacy of various antiviral-based strategies to treat chronic hepatitis patients with positivity for hepatitis B e antigen and rtN236T mutation].
    Yue W; Yuan H; Mao XR; Deng YD; Chen L
    Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):184-8. PubMed ID: 23967738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum alanine aminotransferase flares during interferon treatment of chronic hepatitis B: is sustained clearance of HBV DNA dependent on levels of pretreatment viremia?
    Nair S; Perrillo RP
    Hepatology; 2001 Nov; 34(5):1021-6. PubMed ID: 11679974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic hepatitis B, non-Hodgkin's lymphoma, and effect of prophylactic antiviral therapy.
    Kim YM; Jeong SH; Kim JW; Lee SH; Hwang JH; Park YS; Kim N; Lee JS; Kim HY; Lee DH
    J Clin Virol; 2011 Aug; 51(4):241-5. PubMed ID: 21628103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALT and viral load decline during PEG-IFN alpha-2b treatment for HBeAg-positive chronic hepatitis B.
    ter Borg MJ; Hansen BE; Bigot G; Haagmans BL; Janssen HL
    J Clin Virol; 2008 Jun; 42(2):160-4. PubMed ID: 18359663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic hepatitis B reactivation: a word of caution regarding the use of systemic glucocorticosteroid therapy.
    Yang CH; Wu TS; Chiu CT
    Br J Dermatol; 2007 Sep; 157(3):587-90. PubMed ID: 17596145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features of acute hepatitis E super-infections on chronic hepatitis B.
    Chen C; Zhang SY; Zhang DD; Li XY; Zhang YL; Li WX; Yan JJ; Wang M; Xun JN; Lu C; Ling Y; Huang YX; Chen L
    World J Gastroenterol; 2016 Dec; 22(47):10388-10397. PubMed ID: 28058019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B flares in chronic hepatitis B: pathogenesis, natural course, and management.
    Chang ML; Liaw YF
    J Hepatol; 2014 Dec; 61(6):1407-17. PubMed ID: 25178562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus reactivation after radiofrequency ablation or hepatic resection for HBV-related small hepatocellular carcinoma: a retrospective study.
    Dan JQ; Zhang YJ; Huang JT; Chen MS; Gao HJ; Peng ZW; Xu L; Lau WY
    Eur J Surg Oncol; 2013 Aug; 39(8):865-72. PubMed ID: 23597497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Bcr-Abl Tyrosine Kinase Inhibitors With Hepatitis B Virus Reactivation Requiring Antiviral Treatment in Taiwan.
    Wang LY; Chu SC; Lo Y; Yang YY; Chan KA
    JAMA Netw Open; 2021 Apr; 4(4):e214132. PubMed ID: 33822067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.